Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement in Activity to Date

… Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement in Activity to Date …

Prof. Caroline Dive Honored with Mary J. Matthews Pathology/Translational Research Award for Work with CTCs

Recurrence Remains a Risk Even for Patients Diagnosed via Screening